Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data

GA Figtree, ST Vernon, N Hadziosmanovic… - The Lancet, 2021 - thelancet.com
Background In cardiovascular disease, prevention strategies targeting standard modifiable
cardiovascular risk factors (SMuRFs; hypertension, diabetes, hypercholesterolaemia, and …

ST‐segment–elevation myocardial infarction (STEMI) patients without standard modifiable cardiovascular risk factors—how common are they, and what are their …

ST Vernon, S Coffey, M D'Souza, CK Chow… - Journal of the …, 2019 - Am Heart Assoc
Background Programs targeting the standard modifiable cardiovascular risk factors (SMuRFs:
hypertension, diabetes mellitus, hypercholesterolemia, smoking) are critical to tackling …

Increasing proportion of ST elevation myocardial infarction patients with coronary atherosclerosis poorly explained by standard modifiable risk factors

ST Vernon, S Coffey, R Bhindi… - European journal of …, 2017 - academic.oup.com
Aims Identification and management of the Standard Modifiable Cardiovascular Risk Factors
(SMuRFs; hypercholesterolaemia, hypertension, diabetes and smoking) has substantially …

Higher mortality in acute coronary syndrome patients without standard modifiable risk factors: results from a global meta-analysis of 1,285,722 patients

…, OZH Lim, CH Ng, M Muthiah, R Foo, ST Vernon… - International Journal of …, 2023 - Elsevier
Background Standard modifiable cardiovascular risk factors (SMuRF), comprising diabetes,
hyperlipidemia, hypertension, and smoking, are used for risk stratification in acute coronary …

Utilizing state‐of‐the‐art “omics” technology and bioinformatics to identify new biological mechanisms and biomarkers for coronary artery disease

ST Vernon, T Hansen, KA Kott, JY Yang… - …, 2019 - Wiley Online Library
Identification of the four standard modifiable cardiovascular risk factors (SMuRFs)—diabetes
mellitus, hyperlipidaemia, hypertension, and cigarette smoking—has allowed the …

Integrating a polygenic risk score for coronary artery disease as a risk‐enhancing factor in the pooled cohort equation: a cost‐effectiveness analysis study

D Mujwara, G Henno, ST Vernon, S Peng… - Journal of the …, 2022 - Am Heart Assoc
Background Cardiovascular diseases are the leading cause of death in the United States,
yet a significant proportion of adults at high risk remain undetected by standard screening …

Coronary artery disease in the absence of traditional risk factors: a call for action

SR Avis, ST Vernon, E Hagström… - European Heart …, 2021 - academic.oup.com
The key role of hypertension, hypercholesterolaemia, diabetes mellitus, and smoking in
causing coronary artery disease (CAD) has been well-recognized at a population level and has …

Noninvasive plaque imaging to accelerate coronary artery disease drug development

…, DE Newby, S Patel, K Peter, PJ Psaltis, ST Vernon… - Circulation, 2022 - Am Heart Assoc
Coronary artery disease (CAD) remains the leading cause of adult mortality globally. Targeting
known modifiable risk factors has had substantial benefit, but there remains a need for …

Immunoglobulin E Sensitization to Mammalian Oligosaccharide Galactose-α-1, 3 (α-Gal) Is Associated With Noncalcified Plaque, Obstructive Coronary Artery Disease …

ST Vernon, KA Kott, T Hansen, M Finemore… - … and Vascular Biology, 2022 - Am Heart Assoc
Background: Treating known risk factors for coronary artery disease (CAD) has substantially
reduced CAD morbidity and mortality. However, a significant burden of CAD remains …

Biobanking for discovery of novel cardiovascular biomarkers using imaging-quantified disease burden: protocol for the longitudinal, prospective, BioHEART-CT cohort …

KA Kott, ST Vernon, T Hansen, C Yu, KJ Bubb… - BMJ open, 2019 - bmjopen.bmj.com
Introduction Coronary artery disease (CAD) persists as a major cause of morbidity and
mortality worldwide despite intensive identification and treatment of traditional risk factors. Data …